Evidence map›Paper›PMID 40520988›Full record

ArticleGenes & diseases2025

Clinical impact of the TPM1 p.Tyr221Cys variant causing hypertrophic cardiomyopathy.

Alessio Marinelli, Giuliana Longo, Vincenzo Cirigliano, Esther Campopiano, Clementina Dugo, Luca Ghiselli, Andrea Chiampan, Gianluca Ferri, Alessandro Costa, Stefano Bonapace and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes & diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alessio MarinelliIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.
Giuliana LongoVeritas Intercontinental, C/Orense 58, 2º, Madrid 28020, Spain.
Vincenzo CiriglianoVeritas Intercontinental, C/Orense 58, 2º, Madrid 28020, Spain.
Esther CampopianoIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.
Clementina DugoIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.
Luca GhiselliIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.
Andrea ChiampanIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.
Gianluca FerriIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.
Alessandro CostaIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.
Stefano BonapaceIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.
Laura LanzoniIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.
Giulio MolonIRCCS Sacro Cuore Don Calabria, Don Angelo Sempreboni street n.5, Negrar di Valpolicella 37024, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40520988
PMCPMC12166675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.